世界の乗り物酔い治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Motion Sickness Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3920 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、乗り物酔い治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、抗ヒスタミン薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・乗り物酔い治療の市場動向 ・企業の競争状況、市場シェア ・乗り物酔い治療の種類別市場規模（抗コリン作用薬、抗ヒスタミン薬、その他） ・乗り物酔い治療の用途別市場規模（病院、クリニック、その他） ・乗り物酔い治療の北米市場規模2016-2027（アメリカ、カナダ） ・乗り物酔い治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・乗り物酔い治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・乗り物酔い治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・乗り物酔い治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline、Perrigo Company、Prestige Brands、WellSpring Pharmaceutical Corporation、Caleb Pharmaceuticals、Myungmoon Pharm、Baxter International、Reliefband Technologies） ・結論

Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
Motion sickness is a common condition experienced by around 50% to 60% of the general global population. It is more common in children and elderly. Various prescription and over the counter (OTC) drugs and products are available for treat motion sickness.

Market Analysis and Insights: Global Motion Sickness Treatment Market
The global Motion Sickness Treatment market size is projected to reach US$ 653 million by 2026, from US$ 552.1 million in 2019, at a CAGR of 2.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Motion Sickness Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Motion Sickness Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Motion Sickness Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Motion Sickness Treatment market.

Global Motion Sickness Treatment Scope and Market Size
Motion Sickness Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Motion Sickness Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Anticholinergic
Antihistamines
Others

Segment by Application
Hospitals
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Perrigo Company
Prestige Brands
WellSpring Pharmaceutical Corporation
Caleb Pharmaceuticals
Myungmoon Pharm
Baxter International
Reliefband Technologies

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Motion Sickness Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anticholinergic
1.2.3 Antihistamines
1.2.4 Others
1.3 Market by Application
1.3.1 Global Motion Sickness Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Motion Sickness Treatment Market Perspective (2016-2027)
2.2 Motion Sickness Treatment Growth Trends by Regions
2.2.1 Motion Sickness Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Motion Sickness Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Motion Sickness Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Motion Sickness Treatment Industry Dynamic
2.3.1 Motion Sickness Treatment Market Trends
2.3.2 Motion Sickness Treatment Market Drivers
2.3.3 Motion Sickness Treatment Market Challenges
2.3.4 Motion Sickness Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Motion Sickness Treatment Players by Revenue
3.1.1 Global Top Motion Sickness Treatment Players by Revenue (2016-2021)
3.1.2 Global Motion Sickness Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Motion Sickness Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Motion Sickness Treatment Revenue
3.4 Global Motion Sickness Treatment Market Concentration Ratio
3.4.1 Global Motion Sickness Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Motion Sickness Treatment Revenue in 2020
3.5 Motion Sickness Treatment Key Players Head office and Area Served
3.6 Key Players Motion Sickness Treatment Product Solution and Service
3.7 Date of Enter into Motion Sickness Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Motion Sickness Treatment Breakdown Data by Type
4.1 Global Motion Sickness Treatment Historic Market Size by Type (2016-2021)
4.2 Global Motion Sickness Treatment Forecasted Market Size by Type (2022-2027)

5 Motion Sickness Treatment Breakdown Data by Application
5.1 Global Motion Sickness Treatment Historic Market Size by Application (2016-2021)
5.2 Global Motion Sickness Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Motion Sickness Treatment Market Size (2016-2027)
6.2 North America Motion Sickness Treatment Market Size by Type
6.2.1 North America Motion Sickness Treatment Market Size by Type (2016-2021)
6.2.2 North America Motion Sickness Treatment Market Size by Type (2022-2027)
6.2.3 North America Motion Sickness Treatment Market Size by Type (2016-2027)
6.3 North America Motion Sickness Treatment Market Size by Application
6.3.1 North America Motion Sickness Treatment Market Size by Application (2016-2021)
6.3.2 North America Motion Sickness Treatment Market Size by Application (2022-2027)
6.3.3 North America Motion Sickness Treatment Market Size by Application (2016-2027)
6.4 North America Motion Sickness Treatment Market Size by Country
6.4.1 North America Motion Sickness Treatment Market Size by Country (2016-2021)
6.4.2 North America Motion Sickness Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Motion Sickness Treatment Market Size (2016-2027)
7.2 Europe Motion Sickness Treatment Market Size by Type
7.2.1 Europe Motion Sickness Treatment Market Size by Type (2016-2021)
7.2.2 Europe Motion Sickness Treatment Market Size by Type (2022-2027)
7.2.3 Europe Motion Sickness Treatment Market Size by Type (2016-2027)
7.3 Europe Motion Sickness Treatment Market Size by Application
7.3.1 Europe Motion Sickness Treatment Market Size by Application (2016-2021)
7.3.2 Europe Motion Sickness Treatment Market Size by Application (2022-2027)
7.3.3 Europe Motion Sickness Treatment Market Size by Application (2016-2027)
7.4 Europe Motion Sickness Treatment Market Size by Country
7.4.1 Europe Motion Sickness Treatment Market Size by Country (2016-2021)
7.4.2 Europe Motion Sickness Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Motion Sickness Treatment Market Size (2016-2027)
8.2 Asia-Pacific Motion Sickness Treatment Market Size by Type
8.2.1 Asia-Pacific Motion Sickness Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Motion Sickness Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Motion Sickness Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Motion Sickness Treatment Market Size by Application
8.3.1 Asia-Pacific Motion Sickness Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Motion Sickness Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Motion Sickness Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Motion Sickness Treatment Market Size by Region
8.4.1 Asia-Pacific Motion Sickness Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Motion Sickness Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Motion Sickness Treatment Market Size (2016-2027)
9.2 Latin America Motion Sickness Treatment Market Size by Type
9.2.1 Latin America Motion Sickness Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Motion Sickness Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Motion Sickness Treatment Market Size by Type (2016-2027)
9.3 Latin America Motion Sickness Treatment Market Size by Application
9.3.1 Latin America Motion Sickness Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Motion Sickness Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Motion Sickness Treatment Market Size by Application (2016-2027)
9.4 Latin America Motion Sickness Treatment Market Size by Country
9.4.1 Latin America Motion Sickness Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Motion Sickness Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Motion Sickness Treatment Market Size (2016-2027)
10.2 Middle East & Africa Motion Sickness Treatment Market Size by Type
10.2.1 Middle East & Africa Motion Sickness Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Motion Sickness Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Motion Sickness Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Motion Sickness Treatment Market Size by Application
10.3.1 Middle East & Africa Motion Sickness Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Motion Sickness Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Motion Sickness Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Motion Sickness Treatment Market Size by Country
10.4.1 Middle East & Africa Motion Sickness Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Motion Sickness Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Motion Sickness Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Motion Sickness Treatment Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Perrigo Company
11.2.1 Perrigo Company Company Details
11.2.2 Perrigo Company Business Overview
11.2.3 Perrigo Company Motion Sickness Treatment Introduction
11.2.4 Perrigo Company Revenue in Motion Sickness Treatment Business (2016-2021)
11.2.5 Perrigo Company Recent Development
11.3 Prestige Brands
11.3.1 Prestige Brands Company Details
11.3.2 Prestige Brands Business Overview
11.3.3 Prestige Brands Motion Sickness Treatment Introduction
11.3.4 Prestige Brands Revenue in Motion Sickness Treatment Business (2016-2021)
11.3.5 Prestige Brands Recent Development
11.4 WellSpring Pharmaceutical Corporation
11.4.1 WellSpring Pharmaceutical Corporation Company Details
11.4.2 WellSpring Pharmaceutical Corporation Business Overview
11.4.3 WellSpring Pharmaceutical Corporation Motion Sickness Treatment Introduction
11.4.4 WellSpring Pharmaceutical Corporation Revenue in Motion Sickness Treatment Business (2016-2021)
11.4.5 WellSpring Pharmaceutical Corporation Recent Development
11.5 Caleb Pharmaceuticals
11.5.1 Caleb Pharmaceuticals Company Details
11.5.2 Caleb Pharmaceuticals Business Overview
11.5.3 Caleb Pharmaceuticals Motion Sickness Treatment Introduction
11.5.4 Caleb Pharmaceuticals Revenue in Motion Sickness Treatment Business (2016-2021)
11.5.5 Caleb Pharmaceuticals Recent Development
11.6 Myungmoon Pharm
11.6.1 Myungmoon Pharm Company Details
11.6.2 Myungmoon Pharm Business Overview
11.6.3 Myungmoon Pharm Motion Sickness Treatment Introduction
11.6.4 Myungmoon Pharm Revenue in Motion Sickness Treatment Business (2016-2021)
11.6.5 Myungmoon Pharm Recent Development
11.7 Baxter International
11.7.1 Baxter International Company Details
11.7.2 Baxter International Business Overview
11.7.3 Baxter International Motion Sickness Treatment Introduction
11.7.4 Baxter International Revenue in Motion Sickness Treatment Business (2016-2021)
11.7.5 Baxter International Recent Development
11.8 Reliefband Technologies
11.8.1 Reliefband Technologies Company Details
11.8.2 Reliefband Technologies Business Overview
11.8.3 Reliefband Technologies Motion Sickness Treatment Introduction
11.8.4 Reliefband Technologies Revenue in Motion Sickness Treatment Business (2016-2021)
11.8.5 Reliefband Technologies Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Motion Sickness Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anticholinergic
Table 3. Key Players of Antihistamines
Table 4. Key Players of Others
Table 5. Global Motion Sickness Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Motion Sickness Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Motion Sickness Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Motion Sickness Treatment Market Share by Regions (2016-2021)
Table 9. Global Motion Sickness Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Motion Sickness Treatment Market Share by Regions (2022-2027)
Table 11. Motion Sickness Treatment Market Trends
Table 12. Motion Sickness Treatment Market Drivers
Table 13. Motion Sickness Treatment Market Challenges
Table 14. Motion Sickness Treatment Market Restraints
Table 15. Global Motion Sickness Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Motion Sickness Treatment Market Share by Players (2016-2021)
Table 17. Global Top Motion Sickness Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Motion Sickness Treatment as of 2020)
Table 18. Ranking of Global Top Motion Sickness Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Motion Sickness Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Motion Sickness Treatment Product Solution and Service
Table 22. Date of Enter into Motion Sickness Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Motion Sickness Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Motion Sickness Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Motion Sickness Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Motion Sickness Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Motion Sickness Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Motion Sickness Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Motion Sickness Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Motion Sickness Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Motion Sickness Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Motion Sickness Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Motion Sickness Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Motion Sickness Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Motion Sickness Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Motion Sickness Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Motion Sickness Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Motion Sickness Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Motion Sickness Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Motion Sickness Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Motion Sickness Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Motion Sickness Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Motion Sickness Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Motion Sickness Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Motion Sickness Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Motion Sickness Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Motion Sickness Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Motion Sickness Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Motion Sickness Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Motion Sickness Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Motion Sickness Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Motion Sickness Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Motion Sickness Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Motion Sickness Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Motion Sickness Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Motion Sickness Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Motion Sickness Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Motion Sickness Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Motion Sickness Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Motion Sickness Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. GlaxoSmithKline Company Details
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline Motion Sickness Treatment Product
Table 65. GlaxoSmithKline Revenue in Motion Sickness Treatment Business (2016-2021) & (US$ Million)
Table 66. GlaxoSmithKline Recent Development
Table 67. Perrigo Company Company Details
Table 68. Perrigo Company Business Overview
Table 69. Perrigo Company Motion Sickness Treatment Product
Table 70. Perrigo Company Revenue in Motion Sickness Treatment Business (2016-2021) & (US$ Million)
Table 71. Perrigo Company Recent Development
Table 72. Prestige Brands Company Details
Table 73. Prestige Brands Business Overview
Table 74. Prestige Brands Motion Sickness Treatment Product
Table 75. Prestige Brands Revenue in Motion Sickness Treatment Business (2016-2021) & (US$ Million)
Table 76. Prestige Brands Recent Development
Table 77. WellSpring Pharmaceutical Corporation Company Details
Table 78. WellSpring Pharmaceutical Corporation Business Overview
Table 79. WellSpring Pharmaceutical Corporation Motion Sickness Treatment Product
Table 80. WellSpring Pharmaceutical Corporation Revenue in Motion Sickness Treatment Business (2016-2021) & (US$ Million)
Table 81. WellSpring Pharmaceutical Corporation Recent Development
Table 82. Caleb Pharmaceuticals Company Details
Table 83. Caleb Pharmaceuticals Business Overview
Table 84. Caleb Pharmaceuticals Motion Sickness Treatment Product
Table 85. Caleb Pharmaceuticals Revenue in Motion Sickness Treatment Business (2016-2021) & (US$ Million)
Table 86. Caleb Pharmaceuticals Recent Development
Table 87. Myungmoon Pharm Company Details
Table 88. Myungmoon Pharm Business Overview
Table 89. Myungmoon Pharm Motion Sickness Treatment Product
Table 90. Myungmoon Pharm Revenue in Motion Sickness Treatment Business (2016-2021) & (US$ Million)
Table 91. Myungmoon Pharm Recent Development
Table 92. Baxter International Company Details
Table 93. Baxter International Business Overview
Table 94. Baxter International Motion Sickness Treatment Product
Table 95. Baxter International Revenue in Motion Sickness Treatment Business (2016-2021) & (US$ Million)
Table 96. Baxter International Recent Development
Table 97. Reliefband Technologies Company Details
Table 98. Reliefband Technologies Business Overview
Table 99. Reliefband Technologies Revenue in Motion Sickness Treatment Business (2016-2021) & (US$ Million)
Table 100. Reliefband Technologies Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Motion Sickness Treatment Market Share by Type: 2020 VS 2027
Figure 2. Anticholinergic Features
Figure 3. Antihistamines Features
Figure 4. Others Features
Figure 5. Global Motion Sickness Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Motion Sickness Treatment Report Years Considered
Figure 10. Global Motion Sickness Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Motion Sickness Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Motion Sickness Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Motion Sickness Treatment Market Share by Regions (2022-2027)
Figure 14. Global Motion Sickness Treatment Market Share by Players in 2020
Figure 15. Global Top Motion Sickness Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Motion Sickness Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Motion Sickness Treatment Revenue in 2020
Figure 17. Global Motion Sickness Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Motion Sickness Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Motion Sickness Treatment Market Share by Type (2016-2027)
Figure 21. North America Motion Sickness Treatment Market Share by Application (2016-2027)
Figure 22. North America Motion Sickness Treatment Market Share by Country (2016-2027)
Figure 23. United States Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Motion Sickness Treatment Market Share by Type (2016-2027)
Figure 27. Europe Motion Sickness Treatment Market Share by Application (2016-2027)
Figure 28. Europe Motion Sickness Treatment Market Share by Country (2016-2027)
Figure 29. Germany Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Motion Sickness Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Motion Sickness Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Motion Sickness Treatment Market Share by Region (2016-2027)
Figure 39. China Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Motion Sickness Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Motion Sickness Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Motion Sickness Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Motion Sickness Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Motion Sickness Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Motion Sickness Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Motion Sickness Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Motion Sickness Treatment Business (2016-2021)
Figure 59. Perrigo Company Revenue Growth Rate in Motion Sickness Treatment Business (2016-2021)
Figure 60. Prestige Brands Revenue Growth Rate in Motion Sickness Treatment Business (2016-2021)
Figure 61. WellSpring Pharmaceutical Corporation Revenue Growth Rate in Motion Sickness Treatment Business (2016-2021)
Figure 62. Caleb Pharmaceuticals Revenue Growth Rate in Motion Sickness Treatment Business (2016-2021)
Figure 63. Myungmoon Pharm Revenue Growth Rate in Motion Sickness Treatment Business (2016-2021)
Figure 64. Baxter International Revenue Growth Rate in Motion Sickness Treatment Business (2016-2021)
Figure 65. Reliefband Technologies Revenue Growth Rate in Motion Sickness Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---